company background image
BPC logo

Birzeit Pharmaceuticals PLSE:BPC Stock Report

Last Price

US$3.85

Market Cap

US$149.2m

7D

-3.0%

1Y

-7.2%

Updated

13 Jun, 2024

Data

Company Financials

Birzeit Pharmaceuticals Company

PLSE:BPC Stock Report

Market Cap: US$149.2m

Birzeit Pharmaceuticals Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Birzeit Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.85
52 Week HighUS$4.46
52 Week LowUS$3.85
Beta0
1 Month Change-5.87%
3 Month Change-8.98%
1 Year Change-7.23%
3 Year Change48.08%
5 Year Change61.94%
Change since IPO202.20%

Recent News & Updates

Recent updates

Shareholder Returns

BPCPS PharmaceuticalsPS Market
7D-3.0%-0.05%0.2%
1Y-7.2%3.5%-15.3%

Return vs Industry: BPC underperformed the PS Pharmaceuticals industry which returned 3.5% over the past year.

Return vs Market: BPC exceeded the PS Market which returned -15.3% over the past year.

Price Volatility

Is BPC's price volatile compared to industry and market?
BPC volatility
BPC Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement3.5%
10% most volatile stocks in PS Market5.3%
10% least volatile stocks in PS Market2.5%

Stable Share Price: BPC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BPC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1973n/aTalal Kadhim Nasereddinbpc.ps

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, and supplements; and skin/topical care, allergy and cold, eye care, mouth and nose care, pain and fever, and digestion and gastrointestinal products.

Birzeit Pharmaceuticals Company Fundamentals Summary

How do Birzeit Pharmaceuticals's earnings and revenue compare to its market cap?
BPC fundamental statistics
Market capUS$149.24m
Earnings (TTM)US$2.89m
Revenue (TTM)US$42.01m

51.7x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BPC income statement (TTM)
RevenueUS$42.01m
Cost of RevenueUS$27.98m
Gross ProfitUS$14.03m
Other ExpensesUS$11.14m
EarningsUS$2.89m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.075
Gross Margin33.40%
Net Profit Margin6.88%
Debt/Equity Ratio0%

How did BPC perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

67%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.